How DNA Origami Disrupts Medicine and Becomes the Cornerstone of Nano Robotics
The most exciting breakthroughs happen when different fields of research come together – like in DNA Origami where digital technology, biology and nano technology are coming together and promise advances in medicine and nano robotics.
Imagine better ways to treat cancer or build tailor-made traps for viruses, for example.
This session features presentations by Christian Sigl of capsitec, Jean-Philippe Sobczak of tilibit nanosystems, Klaus Wagenbauer of Plectonic Biotech and Hendrik Dietz of the Technical University Munich (TUM), in conversation with Nicola Kegel of Nanogami and innovation manager at SPRIND, the German Federal Agency for Disruptive Innovation.
Technical University Munich
Hendrik Dietz is a renowned physicist and leader in the field of DNA nanotechnology. A winner of several awards, he leads the Bionanotech & Molecular Robotics Lab at Technical University Munich.
An expert in DNA nanotechnology, Christian Sigl is the founder and CEO of capsitec, a healthtech startup that has developed a programmable antiviral drug platform called “virus trap.”
Jean-Philippe Sobczak is the CEO of tilibit nanosystems, a company at the intersection of nanotechnology, health, and sensing. The technology is based on Sobczak’s research developing improved methods for producing nanostructures.
Nicola Kegel is CEO of Nanogami, a startup that develops DNA origami nanotechnology for molecular diagnostics and cancer treatment. In addition, she serves as an Innovation Manager for the Federal Agency of Disruptive Innovation (SPRIN-D).